{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:52:33Z","timestamp":1778860353881,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.exphem.2026.105402","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:50:37Z","timestamp":1772038237000},"page":"105402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gremlin-1 promotes leukemic survival via PI3K\/AKT signaling in infant MLL-AF4\u2013positive B-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"157","author":[{"given":"Xiaotian","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3316-694X","authenticated-orcid":false,"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105402_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2023023154","article-title":"How I treat infant acute lymphoblastic leukemia","volume":"145","author":"Bartram","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105402_bib0002","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2026.105402_bib0003","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2026.105402_bib0004","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/10935266211001308","article-title":"Lineage Switch in an infant B-lymphoblastic leukemia with t(1;11)(p32;q23); KMT2A\/EPS15, following blinatumomab therapy","volume":"24","author":"Du","year":"2021","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.exphem.2026.105402_bib0005","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/bloodadvances.2020004157","article-title":"Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia","volume":"5","author":"Takachi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2026.105402_bib0006","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3324\/haematol.2022.281552","article-title":"KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study","volume":"108","author":"Robinson","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2026.105402_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-022-01251-1","article-title":"Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias","volume":"15","author":"Yi","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2026.105402_bib0008","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.2023022050","article-title":"NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression","volume":"144","author":"Lopez-Millan","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2026.105402_bib0009","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41375-020-0808-y","article-title":"H3K79me2\/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1\/CD133 in MLL-AF4 leukemia cells","volume":"35","author":"Godfrey","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2026.105402_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70326","article-title":"Recent developments and evolving therapeutic strategies in KMT2A-rearranged acute leukemia","volume":"13","author":"Yin","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.exphem.2026.105402_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109559","article-title":"RSPO2 inhibits BMP signaling to promote self-renewal in acute myeloid leukemia","volume":"36","author":"Sun","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2026.105402_bib0012","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","article-title":"The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis","volume":"160","author":"Kobayashi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exphem.2026.105402_bib0013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41586-022-04888-7","article-title":"GREM1 is required to maintain cellular heterogeneity in pancreatic cancer","volume":"607","author":"Lan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2026.105402_bib0014","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1158\/2159-8290.CD-RW2022-0124","article-title":"GREM1 restricts plasticity and maintains heterogeneity in pancreatic cancer","volume":"12","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2026.105402_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178002","article-title":"GREM1: dual roles in cancer and fibrosis with emerging therapeutic opportunities","volume":"1004","author":"Elizarrar\u00e1s-Rivas","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.exphem.2026.105402_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13058-019-1194-0","article-title":"Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression","volume":"21","author":"Ren","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.exphem.2026.105402_bib0017","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.exphem.2026.105402_bib0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2026.105402_bib0019","first-page":"1713","article-title":"CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia","volume":"109","author":"Cardoso","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2026.105402_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120326","article-title":"Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2026.105402_bib0021","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.stemcr.2016.08.013","article-title":"Development refractoriness of MLL-rearranged human B cell acute leukemias to reprogramming into pluripotency","volume":"7","author":"Mu\u00f1oz-L\u00f3pez","year":"2016","journal-title":"Stem Cell Reports"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:13:20Z","timestamp":1777547600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"alternative-id":["S0301472X26000354"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105402","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gremlin-1 promotes leukemic survival via PI3K\/AKT signaling in infant MLL-AF4\u2013positive B-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105402"}}